Longitudinal change in CDC42 in psoriasis: correlation with disease activity and treatment response
Conclusion: Increased serum CDC42 level reflects reduced disease severity and better treatment response in patients with psoriasis.PMID:37934043 | DOI:10.2217/bmm-2023-0425 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - November 7, 2023 Category: Internal Medicine Authors: Bing Xu Leiqiang Fan Qiaoli Liu Bin Guo Tao Yang Yanfeng Zhang Source Type: research

Recent progress in biomarker-based diagnostics of < em > Helicobacter pylori < /em > , gastric cancer-causing bacteria
Biomark Med. 2023 Nov 7. doi: 10.2217/bmm-2023-0316. Online ahead of print.ABSTRACTThe progression of any disease and its outcomes depend on the complicated interaction between pathogens, host and environmental factors. Thus, complete knowledge of bacterial toxins involved in pathogenesis is necessary to develop diagnostic methods and alternative therapies, including vaccines. This review summarizes recently employed biomarkers to diagnose the presence of Helicobacter pylori bacteria. The authors review distinct types of disease-associated biomarkers such as urease, DNA, miRNA, aptamers and bacteriophages that can be utili...
Source: Future Medicine: Biomarkers in Medicine - November 7, 2023 Category: Internal Medicine Authors: Kirti Saxena Akanksha Deshwal Ramesh Namdeo Pudake Utkarsh Jain Ravi Mani Tripathi Source Type: research

A novel cuproptosis-related lncRNA prognostic signature in thyroid cancer
Conclusion: The model may help to screen out thyroid cancer patients at high risk, and thus develop more appropriate treatment strategies.PMID:37934030 | DOI:10.2217/bmm-2023-0216 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - November 7, 2023 Category: Internal Medicine Authors: Lujia Liu Jie Xu Xifeng Sun Haitao Zheng Source Type: research

Diagnostic value of < em > circRNA < /em > in coronary heart disease: a meta-analysis
Conclusion: circRNAs may be good biomarkers for diagnosing CHD.PMID:37934042 | DOI:10.2217/bmm-2023-0369 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - November 7, 2023 Category: Internal Medicine Authors: Ming-Zhu Li Jia-Nan Zhang Fei Ren De-Lu Yin Xin-Hua Zhao Kun Liu Source Type: research

Longitudinal change in CDC42 in psoriasis: correlation with disease activity and treatment response
Conclusion: Increased serum CDC42 level reflects reduced disease severity and better treatment response in patients with psoriasis.PMID:37934043 | DOI:10.2217/bmm-2023-0425 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - November 7, 2023 Category: Internal Medicine Authors: Bing Xu Leiqiang Fan Qiaoli Liu Bin Guo Tao Yang Yanfeng Zhang Source Type: research

Recent progress in biomarker-based diagnostics of < em > Helicobacter pylori < /em > , gastric cancer-causing bacteria
Biomark Med. 2023 Nov 7. doi: 10.2217/bmm-2023-0316. Online ahead of print.ABSTRACTThe progression of any disease and its outcomes depend on the complicated interaction between pathogens, host and environmental factors. Thus, complete knowledge of bacterial toxins involved in pathogenesis is necessary to develop diagnostic methods and alternative therapies, including vaccines. This review summarizes recently employed biomarkers to diagnose the presence of Helicobacter pylori bacteria. The authors review distinct types of disease-associated biomarkers such as urease, DNA, miRNA, aptamers and bacteriophages that can be utili...
Source: Future Medicine: Biomarkers in Medicine - November 7, 2023 Category: Internal Medicine Authors: Kirti Saxena Akanksha Deshwal Ramesh Namdeo Pudake Utkarsh Jain Ravi Mani Tripathi Source Type: research

Feasibility evaluation of hsa_circ_0005480 as an auxiliary diagnostic and prognostic indicator for gastric cancer
Conclusion: Hsa_circ_0005480 may prove to be a marker for auxiliary diagnosis and prognostic evaluation of GC.PMID:37902590 | DOI:10.2217/bmm-2023-0066 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - October 30, 2023 Category: Internal Medicine Authors: Jiajia Yu Kang Lu Huifang Huang Junyi Wang Qian Yang Source Type: research

Feasibility evaluation of hsa_circ_0005480 as an auxiliary diagnostic and prognostic indicator for gastric cancer
Conclusion: Hsa_circ_0005480 may prove to be a marker for auxiliary diagnosis and prognostic evaluation of GC.PMID:37902590 | DOI:10.2217/bmm-2023-0066 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - October 30, 2023 Category: Internal Medicine Authors: Jiajia Yu Kang Lu Huifang Huang Junyi Wang Qian Yang Source Type: research

< em > EVI2B < /em > may be a novel prognostic marker for lung adenocarcinoma
Conclusion: EVI2B was related to prognosis and immune microenvironment in LUAD, suggesting that EVI2B may be a novel prognostic marker for LUAD.PMID:37843407 | DOI:10.2217/bmm-2023-0195 (Source: Future Medicine: Biomarkers in Medicine)
Source: Future Medicine: Biomarkers in Medicine - October 16, 2023 Category: Internal Medicine Authors: Yin Fu Junming He Jian Chen Jiangwei Hu Wei Guan Guoliang Lou Source Type: research